ArticleJACC. Case reports2026
Circumferential Resection of the Right Atrium to Excise Angiosarcoma.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac angiosarcomas are rare, with no established treatment guidelines. There is limited reporting of large cardiac angiosarcomas requiring extensive atrial resection and reconstruction, and limited data on outcomes after resection with positive margins. CASE SUMMARY: A 51-year-old man with multiple comorbidities was diagnosed with nonmetastatic 7.1 × 5.6 × 4.9 cm primary cardiac angiosarcoma in the right atrium extending into the superior vena cava. The mass was circumferentially resected with reconstruction of the right atrium using bovine pericardial patch. Histopathology confirmed a grade II spindle cell variant angiosarcoma with positive margins. Subsequent management included chemotherapy, targeted therapy, and radiotherapy for metastatic disease. He has had continued survival at 28 months postoperatively. DISCUSSION: Cardiac angiosarcomas can be large and challenging to resect. Aggressive surgical resection may prolong survival, even with positive margins. TAKE-HOME MESSAGE: Extensive surgical resection may improve survival for cardiac angiosarcoma with locally extensive and metastatic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.